SCHEMBL2052808

SCHEMBL2052808

CCCCOC(=O)NC(N)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.56
NPC1 O15118 4/20 0.56
RAB9A P51151 4/20 0.56
LMNA P02545 1/20 0.56
CTSK P43235 2/20 0.50
POLB P06746 1/20 0.50
L3MBTL1 Q9Y468 2/20 0.49
HPGD P15428 1/20 0.49
MAPK1 P28482 1/20 0.48
TDP1 Q9NUW8 2/20 0.47
TSHR P16473 2/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2C19 P33261 2/20 0.47
FAAH O00519 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
ALDH1A1 P00352 1/20 0.46
HSD17B10 Q99714 1/20 0.46
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13387483 0.85 SMN1; SMN2 (0.65) SMN1; SMN2NPC1RAB9ALMNACTSK
SCHEMBL13506655 0.85 NPSR1 (0.58) SMN1; SMN2NPC1RAB9ALMNACTSK
SCHEMBL9359270 0.84 ATM (0.50) SMN1; SMN2NPC1RAB9ALMNAPOLB
SCHEMBL7357011 0.84 SMN1; SMN2 (0.60) SMN1; SMN2NPC1RAB9ALMNACTSK
SCHEMBL9317172 0.84 POLB (0.58) SMN1; SMN2NPC1RAB9ALMNACTSK
SCHEMBL9848391 0.83 SMN1; SMN2 (0.53) SMN1; SMN2NPC1RAB9ALMNACTSK
SCHEMBL9848476 0.83 SMN1; SMN2 (0.53) SMN1; SMN2NPC1RAB9ALMNACTSK
SCHEMBL7454120 0.82 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9ALMNACTSK
SCHEMBL1461981 0.82 ATM (0.60) SMN1; SMN2NPC1RAB9ALMNACTSK
SCHEMBL11491274 0.82 ATM (0.60) SMN1; SMN2NPC1RAB9ALMNACTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011076784-A2 NEW INHIBITORS OF CYCLOPHILINS AND USES THEREOF INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2011-06-30 WO disclosed